WO2003105658A3 - Methods and systems for management of alzheimer's disease - Google Patents
Methods and systems for management of alzheimer's disease Download PDFInfo
- Publication number
- WO2003105658A3 WO2003105658A3 PCT/IL2003/000508 IL0300508W WO03105658A3 WO 2003105658 A3 WO2003105658 A3 WO 2003105658A3 IL 0300508 W IL0300508 W IL 0300508W WO 03105658 A3 WO03105658 A3 WO 03105658A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- disease
- alzheimer
- management
- systems
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36017—External stimulators, e.g. with patch electrodes with leads or electrodes penetrating the skin
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003241131A AU2003241131A1 (en) | 2002-06-14 | 2003-06-13 | Methods and systems for management of alzheimer's disease |
EP03730451A EP1521614A2 (en) | 2002-06-14 | 2003-06-13 | Methods and systems for management of alzheimer's disease |
CA002489341A CA2489341A1 (en) | 2002-06-14 | 2003-06-13 | Methods and systems for management of alzheimer's disease |
US10/952,536 US20050159790A1 (en) | 2000-05-08 | 2004-09-27 | Stimulation for treating and diagnosing conditions |
IL16576404A IL165764A0 (en) | 2002-06-14 | 2004-12-14 | Methods and systems for managment of Alzheimers disease |
US10/518,322 US7640062B2 (en) | 2000-05-08 | 2005-07-08 | Methods and systems for management of alzheimer's disease |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38893102P | 2002-06-14 | 2002-06-14 | |
US60/388,931 | 2002-06-14 | ||
US10/294,310 | 2002-11-14 | ||
US10/294,310 US7146209B2 (en) | 2000-05-08 | 2002-11-14 | Stimulation for treating eye pathologies |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/952,536 Continuation-In-Part US20050159790A1 (en) | 2000-05-08 | 2004-09-27 | Stimulation for treating and diagnosing conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003105658A2 WO2003105658A2 (en) | 2003-12-24 |
WO2003105658A3 true WO2003105658A3 (en) | 2004-03-18 |
Family
ID=29739267
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2003/000508 WO2003105658A2 (en) | 2000-05-08 | 2003-06-13 | Methods and systems for management of alzheimer's disease |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1521614A2 (en) |
AU (1) | AU2003241131A1 (en) |
CA (1) | CA2489341A1 (en) |
WO (1) | WO2003105658A2 (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
US8877190B2 (en) | 2006-11-30 | 2014-11-04 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
US8958881B2 (en) | 2005-08-19 | 2015-02-17 | Brainsgate Ltd. | Neuroprotective electrical stimulation |
US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
US9176150B2 (en) | 2003-01-31 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
JP7265591B2 (en) | 2017-05-30 | 2023-04-26 | 森永乳業株式会社 | Composition for improving brain function |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7117033B2 (en) * | 2000-05-08 | 2006-10-03 | Brainsgate, Ltd. | Stimulation for acute conditions |
WO2001085094A2 (en) | 2000-05-08 | 2001-11-15 | Brainsgate Ltd. | Method and apparatus for stimulating the sphenopalatine ganglion to modify properties of the bbb and cerebral blood flow |
US7684859B2 (en) | 2002-04-25 | 2010-03-23 | Brainsgate Ltd. | Stimulation of the OTIC ganglion for treating medical conditions |
US8010189B2 (en) | 2004-02-20 | 2011-08-30 | Brainsgate Ltd. | SPG stimulation for treating complications of subarachnoid hemorrhage |
US7499748B2 (en) | 2005-04-11 | 2009-03-03 | Cardiac Pacemakers, Inc. | Transvascular neural stimulation device |
US7616990B2 (en) * | 2005-10-24 | 2009-11-10 | Cardiac Pacemakers, Inc. | Implantable and rechargeable neural stimulator |
CN102898519B (en) | 2005-11-30 | 2015-10-28 | Abbvie公司 | Monoclonal antibody of anti-amyloid beta protein and uses thereof |
US7965180B2 (en) | 2006-09-28 | 2011-06-21 | Semiconductor Energy Laboratory Co., Ltd. | Wireless sensor device |
US7860569B2 (en) | 2007-10-18 | 2010-12-28 | Brainsgate, Ltd. | Long-term SPG stimulation therapy for prevention of vascular dementia |
WO2011024159A2 (en) | 2009-08-24 | 2011-03-03 | Refael Hof | Phase-change and shape-change materials |
US9062101B2 (en) | 2010-08-14 | 2015-06-23 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
US9675796B2 (en) | 2013-11-10 | 2017-06-13 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
CN107206082B (en) | 2014-11-25 | 2022-01-11 | 纽菲斯有限公司 | Phase-change nanoparticles |
EP3093043B1 (en) | 2015-05-13 | 2018-11-14 | Brainsgate Ltd. | Implant and delivery system for neural stimulator |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5792100A (en) * | 1995-05-19 | 1998-08-11 | Shantha; T. R. | Treatment method for transsphenoidal stimulation of the pituitary gland and of nerve structures |
US6325475B1 (en) * | 1996-09-06 | 2001-12-04 | Microfab Technologies Inc. | Devices for presenting airborne materials to the nose |
US6338715B1 (en) * | 1999-03-31 | 2002-01-15 | Microfab Technologies, Inc. | Digital olfactometer and method for testing olfactory thresholds |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6287793B1 (en) | 1988-08-19 | 2001-09-11 | Elan Pharmaceuticals, Inc. | Diagnostic methods for alzheimer's disease |
-
2003
- 2003-06-13 EP EP03730451A patent/EP1521614A2/en not_active Withdrawn
- 2003-06-13 CA CA002489341A patent/CA2489341A1/en not_active Abandoned
- 2003-06-13 WO PCT/IL2003/000508 patent/WO2003105658A2/en not_active Application Discontinuation
- 2003-06-13 AU AU2003241131A patent/AU2003241131A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5792100A (en) * | 1995-05-19 | 1998-08-11 | Shantha; T. R. | Treatment method for transsphenoidal stimulation of the pituitary gland and of nerve structures |
US6325475B1 (en) * | 1996-09-06 | 2001-12-04 | Microfab Technologies Inc. | Devices for presenting airborne materials to the nose |
US6338715B1 (en) * | 1999-03-31 | 2002-01-15 | Microfab Technologies, Inc. | Digital olfactometer and method for testing olfactory thresholds |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9176150B2 (en) | 2003-01-31 | 2015-11-03 | AbbVie Deutschland GmbH & Co. KG | Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
US9233245B2 (en) | 2004-02-20 | 2016-01-12 | Brainsgate Ltd. | SPG stimulation |
US8958881B2 (en) | 2005-08-19 | 2015-02-17 | Brainsgate Ltd. | Neuroprotective electrical stimulation |
US8691224B2 (en) | 2005-11-30 | 2014-04-08 | Abbvie Inc. | Anti-Aβ globulomer 5F7 antibodies |
US9540432B2 (en) | 2005-11-30 | 2017-01-10 | AbbVie Deutschland GmbH & Co. KG | Anti-Aβ globulomer 7C6 antibodies |
US8877190B2 (en) | 2006-11-30 | 2014-11-04 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
US9359430B2 (en) | 2006-11-30 | 2016-06-07 | Abbvie Inc. | Abeta conformer selective anti-Abeta globulomer monoclonal antibodies |
US9394360B2 (en) | 2006-11-30 | 2016-07-19 | Abbvie Inc. | Aβ conformer selective anti-Aβ globulomer monoclonal antibodies |
US8895004B2 (en) | 2007-02-27 | 2014-11-25 | AbbVie Deutschland GmbH & Co. KG | Method for the treatment of amyloidoses |
US8987419B2 (en) | 2010-04-15 | 2015-03-24 | AbbVie Deutschland GmbH & Co. KG | Amyloid-beta binding proteins |
JP7265591B2 (en) | 2017-05-30 | 2023-04-26 | 森永乳業株式会社 | Composition for improving brain function |
Also Published As
Publication number | Publication date |
---|---|
CA2489341A1 (en) | 2003-12-24 |
WO2003105658A2 (en) | 2003-12-24 |
AU2003241131A1 (en) | 2003-12-31 |
AU2003241131A8 (en) | 2003-12-31 |
EP1521614A2 (en) | 2005-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003105658A3 (en) | Methods and systems for management of alzheimer's disease | |
ATE507872T1 (en) | DEVICE FOR TREATING EPILEPSY AND RHYTHM DISORDERS | |
SG147442A1 (en) | Methods and reagents for the treatment of immunoinflammatory disorders | |
WO2004052183A3 (en) | Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of parkinson's disease and/or other movement disorders | |
WO2004026246A3 (en) | Methods of treating age associated memory impairment (aami), mild cognitive impairment (mci), and dementias with cell cycle inhibitors | |
WO2003066162A3 (en) | Methods and apparatus for effectuating a change in a neural-function of a patient | |
IL166166A0 (en) | Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders | |
DE69636883D1 (en) | Device for the treatment of sleep apnea by electrical stimulation | |
HK1073608A1 (en) | Treatment of alpha-galactosidase a deficiency | |
ATE542566T1 (en) | CHANNEL SELECTIVE COVERING FOR A MEDICAL SYSTEM | |
DE69925625D1 (en) | METHOD AND DEVICE FOR PREDICTING HUMAN COGNITIVE PERFORMANCE | |
WO2002085449A3 (en) | Magnetic field stimulation techniques | |
WO2003041559A3 (en) | Electrical stimulation of the sympathetic nerve chain | |
AU2003264847A1 (en) | Nerve stimulation for treating spasticity, tremor, muscle weakness, and other motor disorders | |
ATE427771T1 (en) | DEVICE FOR MULTI-SITE TREATMENT OF TACHYCARDIA | |
WO2003030823A3 (en) | Combinations for the treatment of immunoinflammatory disorders | |
EP1254260A4 (en) | Methods for diagnosing and treating heart disease | |
DE60324104D1 (en) | Arylsulfonamidobenzylverbindungen | |
GB0305153D0 (en) | Identification of therapeutic compounds | |
TW200503717A (en) | Substituted 1,4-pyrazine derivatives | |
MXPA04010915A (en) | Dynamic human resources knowledge base and process. | |
WO2002062205A3 (en) | Methods for diagnosing and treating heart disease | |
EP1616499A3 (en) | Beauty treatment apparatus using steam enriched with negative ions | |
PL376347A1 (en) | Method of using (2-imidazolin-2-ylamino) qinoxalines in the treatment of dementia and parkinsons | |
WO2003028536A3 (en) | Methods for diagnosing and treating heart disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10952536 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2489341 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003730451 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 38/MUMNP/2005 Country of ref document: IN |
|
WWP | Wipo information: published in national office |
Ref document number: 2003730451 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2006020299 Country of ref document: US Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10518322 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10518322 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: JP |